LBA51 KEYNOTE-024 5-year OS update: First-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumour proportion score (TPS) ≥50%

Julie Renee Brahmer, Delvys Rodríguez‐Abreu, AE Robinson et al. · Annals of Oncology · 2020

Cited by 92 works. doi:10.1016/j.annonc.2020.08.2284 Open-access PDF

Authors